Features
Motivating Staff in an Optometrist’s Office
Monday, February 5 2018 | 20 h 43 min | EyeCareBusiness.ca,
How do you attract, grow and keep exceptional staff?
Gene Therapy for Vision Loss Approved by FDA
Thursday, January 25 2018 | 00 h 00 min | Vision Science,
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.
Engineer at Simon Fraser Develops High Resolution Retinal Scanner
Thursday, January 11 2018 | 00 h 00 min | Vision Science,
Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.
Essilor Shares Rise Sharply in Past Month
Tuesday, December 12 2017 | 00 h 00 min | Financial News, News, Press Release,
Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.
Cooper Announces Revenue Gains in 2017
Friday, December 8 2017 | 00 h 00 min | Financial News, News, Press Release,
The Cooper Companies, Inc. announced financial results for the fiscal fourth quarter and full year ended October 31, 2017.
Motivating Staff in an Optometrist’s Office
Monday, February 5 2018 | 20 h 43 min | EyeCareBusiness.ca,
How do you attract, grow and keep exceptional staff?
Gene Therapy for Vision Loss Approved by FDA
Thursday, January 25 2018 | 00 h 00 min | Vision Science,
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.
Engineer at Simon Fraser Develops High Resolution Retinal Scanner
Thursday, January 11 2018 | 00 h 00 min | Vision Science,
Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.
Essilor Shares Rise Sharply in Past Month
Tuesday, December 12 2017 | 00 h 00 min | Financial News, News, Press Release,
Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.
Cooper Announces Revenue Gains in 2017
Friday, December 8 2017 | 00 h 00 min | Financial News, News, Press Release,
The Cooper Companies, Inc. announced financial results for the fiscal fourth quarter and full year ended October 31, 2017.
Motivating Staff in an Optometrist’s Office
Monday, February 5 2018 | 20 h 43 min | EyeCareBusiness.ca,
How do you attract, grow and keep exceptional staff?
Gene Therapy for Vision Loss Approved by FDA
Thursday, January 25 2018 | 00 h 00 min | Vision Science,
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.
Engineer at Simon Fraser Develops High Resolution Retinal Scanner
Thursday, January 11 2018 | 00 h 00 min | Vision Science,
Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.
Essilor Shares Rise Sharply in Past Month
Tuesday, December 12 2017 | 00 h 00 min | Financial News, News, Press Release,
Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.
Cooper Announces Revenue Gains in 2017
Friday, December 8 2017 | 00 h 00 min | Financial News, News, Press Release,
The Cooper Companies, Inc. announced financial results for the fiscal fourth quarter and full year ended October 31, 2017.
Motivating Staff in an Optometrist’s Office
Monday, February 5 2018 | 20 h 43 min | EyeCareBusiness.ca,
How do you attract, grow and keep exceptional staff?
Gene Therapy for Vision Loss Approved by FDA
Thursday, January 25 2018 | 00 h 00 min | Vision Science,
A gene therapy treatment for the disease known as “biallelic RPE65 mutation-associated retinal dystrophy,” a rare condition with onset in childhood or adolescence that leads to complete vision loss, was approved by the FDA in December of 2017.
Engineer at Simon Fraser Develops High Resolution Retinal Scanner
Thursday, January 11 2018 | 00 h 00 min | Vision Science,
Marko Sarunic, Engineering Science Professor at Simon Fraser University, has developed a high resolution retinal scanner that can help in diagnosing disease before vision loss occurs.
Essilor Shares Rise Sharply in Past Month
Tuesday, December 12 2017 | 00 h 00 min | Financial News, News, Press Release,
Essilor’s stock price has been on the rise in the last 4 weeks, increasing 5.97% in that span.
Cooper Announces Revenue Gains in 2017
Friday, December 8 2017 | 00 h 00 min | Financial News, News, Press Release,
The Cooper Companies, Inc. announced financial results for the fiscal fourth quarter and full year ended October 31, 2017.
